Is this you?
Request access for Rutgers with your @clinical-trials-office work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Rutgers
Unclaimed profileAcademic Network · Newark, New Jersey · ~Unknown sites
Intera lens
ICP 7Lift (cardio sample) 0.09Recruit soph 0.29
Quality Scorecard (1–100)
Overall82Recruit60Ops82Sponsor95Ther96
Performance (observed)
Historical trials
800
Completed
310
Terminated/Withdrawn
101
Completion rate
75%
Active now
358
Phase 2
278
Phase 3
225
Realized enrollment
332,029
First study year
1999
Years active
27
Match confidence
low (approx)
Enrollment velocity (inf)
12,297
Therapeutic
Areas
General medical, Oncology (CINJ), Immunology, Infectious Diseases
Specialties
Multiple (academic medical center)
Breadth (conditions)
2,016
States
New Jersey
Recruitment (web observed)
Trial Finder
Yes
Recruitment pages
Yes
Capability notes
High - AI-enabled patient recruitment with Deep6 AI integrated with EMR systems (RWJBH, UH-Newark)
Relationships
Sponsors
Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Children's Oncology Group; Merck Sharp & Dohme LLC; AbbVie; NRG Oncology
CROs
Acrotech Biopharma Inc.; Crohn's and Colitis Foundation; IQVIA Biotech; IQVIA Pty Ltd; Syneos Health; The Emmes Company, LLC
Partnerships
NJ ACTS
Owner / parent
Public University (Rutgers, State University of New Jersey), NJ ACTS CTSA Hub
Funding
NIH Grant $39.7M (NJ ACTS, 2024)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Nancy Reilly, RN, MS (Executive Director, Clinical Trials Office)
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
FRIDA_queries@oryzon.com
Tech & DCT
CTMS
OnCore
EHR
Epic
eSource
Yes
Uses AI
Yes
Builds tech
Vendors (OnCore, Deep6, etc.)
DCT / decentralized
Y - Deep6 AI for feasibility & recruitment
Tech stack
OnCore (CTMS), Deep6 AI (patient cohort mining), ClinCard, DocuSign, eReg
Recruiting visible
Y
Notes
Academic network with state-of-the-art Clinical Trials Office (formed 2020), AI-driven recruitment via Deep6, centralized trial management. Serves RWJBH and UH-Newark. ctgov_note: 7 recruiting trials across 3 location(s), states: New Jersey
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.09Overall82
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.